医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

3M Prevails Against Seil Global Co. Ltd. in an Unfair Competition Action Related to 3M’s Dental Mixing Tip Products

2015年11月06日 AM03:56
このエントリーをはてなブックマークに追加


 

ST. PAUL, Minn. & NEUSS, Germany

3M announced today that a German district court ruled in favor of 3M in an unfair competition claim 3M filed against South Korea-based Seil Global Co. Ltd.

The court found Seil’s red-colored dental mixing tips looked confusingly similar to 3M´s dental mixing tips that are recognizable by their unique red color and marketed under the brand 3M™ ESPE™ Penta™ Mixing Tips. The decision is final, which means that Seil is permanently enjoined from selling its red mixing tips in Germany.

3M´s dental mixing tips are well-known in the market and have acquired competitive distinctiveness in Germany. The unique design of the Penta mixing tip that is also covered by a utility patent and a design registration provides users of the 3M™ ESPE™ Pentamix™ Mixing Units with a high quality tip that delivers the most uniform, consistent result. It also facilitates easier extrusion of the impression material.

3M is committed to improving oral care through continuous research and development investments. By protecting its intellectual property and ensuring genuine 3M products are distributed through secure, authorized channels, 3M helps dentists and their patients avoid the use of unauthentic products.

About 3M

At 3M, we apply science in collaborative ways to improve lives daily. With $32 billion in sales, our 90,000 employees connect with customers all around the world. Learn more about 3M’s creative solutions to the world’s problems at www.3M.com or on Twitter @3M or @3MNewsroom.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151105006534/en/

CONTACT

3M
Lori Anderson, 651-733-0831

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Ra Medical Systems Receives Approval in China for Pharos Dermatology Laser
  • Cardiovascular Systems, Inc. Receives Approval for the Diamondback 360® Coronary Orbital Atherectomy System (OAS) Micro Crown in Japan
  • Gynesonics Names James Sparks Vice President of Manufacturing
  • Takeda Announces Ricardo Marek as New President of Emerging Markets Business Unit
  • Takeda’s Dengue Vaccine Candidate Elicited Broad Immune Responses in Children and Adolescents Living in Dengue-Endemic Areas; Interim Phase 2 Analysis Published in The Lancet Infectious Diseases